i2o Therapeutics
Latest round
- Seed
Last raised
- Apr 2020
Total raised
- $4M
Investors
- 2
About i2o Therapeutics
Founded in 2019 and based in Massachusetts, US, i2o Therapeutics, Inc. operates as a biotechnology company that develops oral biologic medicine for the treatment of diabetes.
Who invested in i2o Therapeutics
2 investors across 1 round
See all investors in i2o Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Apr 9, 2020
Amount
$4M
Investors
Questions about i2o Therapeutics
Who invested in i2o Therapeutics?
i2o Therapeutics has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has i2o Therapeutics raised?
i2o Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did i2o Therapeutics last raise money?
i2o Therapeutics's most recent round on record is a Seed, in Apr 2020.
What does i2o Therapeutics do?
Founded in 2019 and based in Massachusetts, US, i2o Therapeutics, Inc.
Where is i2o Therapeutics headquartered?
i2o Therapeutics is headquartered in Cambridge, US.
Which VCs invest in companies like i2o Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at i2o Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like i2o Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.